Avita Medical | Capitale Di Prestito



Loan Capital Cambiamento Data
Adcock Ingram Holdings ZAR 220.08M 18M 2024-12
Celltrion KRW 114.04B 8.35B 2025-03
Clinuvel Pharmaceuticals AUD 509.92K 203.14K 2024-06
Cochlear AUD 203.5M 1.4M 2024-12
CSL USD 9.33B 1.91B 2024-12
Cspc Pharmaceutical CNY 56.14M 10.18M 2024-12
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd 20M 0 2025-03
Kangmei Pharma CNY 169.19M 7.26M 2024-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 80.5M 17.64M 2024-12
Malin Corporation EUR 0 0 2024-12
Mayne Pharma AUD 31.64M 1.47M 2024-06
Medical Developments International AUD 1.76M 150K 2024-12
Nanosonics AUD 5.78M 385K 2024-12
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 43.29M 12.19M 2024-12
Pacific Edge NZD 1.77M 744K 2024-09
Paradigm Biopharmaceuticals AUD 100K 79.43K 2024-12
Pharma Mar EUR 40.24M 992K 2025-03
Polynovo AUD 12.84M 857K 2024-06
PYC Therapeutics AUD 827.09K 24.09K 2024-12
Qiagen NV USD 1.35B 14.58M 2025-03
Ramsay Health Care AUD 10.69B 359.3M 2024-12
ResMed USD 662.86M 4.72M 2024-12
Sartorius EUR 4.2B 178.6M 2025-03
Sino Biopharmaceutical CNY 2.08B 915.47M 2024-12
Telix Pharmaceuticals AUD 551.82M 533.46M 2024-12
Tilray USD 316.63M 15.02M 2024-11
Zz Pientze Pharmaceu 204.54M 8.18M 2025-03



Avita Medical Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jun 2025.